Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Leishmaniasis, Visceral

quinazolines has been researched along with Leishmaniasis, Visceral in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ankur, V; Kumar, SP; Kumar, SS; Mahender, T; Pankaj, W1
Dujardin, JC; Kyle, DE; Manetsch, R; Pandharkar, T; Rijal, S; Van Horn, KS; Vanaerschot, M; Vesely, B; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X1
Barber, MM; Manetsch, R; Van Horn, KS; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X1
Ali, N; Bhattacharyya, A; Chhajer, R; Das, N; Didwania, N; Palit, P; Shadab, M; Vaidya, T1
Feiz Barazandeh, A; Jia, P; Keynan, Y; Khadem, F; Liu, D; Mou, Z; Uzonna, JE1

Reviews

1 review(s) available for quinazolines and Leishmaniasis, Visceral

ArticleYear
Some Scaffolds as Anti-leishmanial Agents: A Review.
    Mini reviews in medicinal chemistry, 2022, Volume: 22, Issue:5

    Topics: Antiprotozoal Agents; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Quinazolines

2022

Other Studies

4 other study(ies) available for quinazolines and Leishmaniasis, Visceral

ArticleYear
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
    Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12

    Topics: Animals; Antimony; Cell Line; Diamines; Drug Resistance; Leishmania; Leishmania donovani; Leishmania mexicana; Leishmaniasis, Visceral; Macrophages; Male; Mice, Inbred BALB C; Quinazolines; Structure-Activity Relationship; Trypanocidal Agents

2014
SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
    Bioorganic & medicinal chemistry, 2015, Aug-15, Volume: 23, Issue:16

    Topics: Animals; Antiprotozoal Agents; Diamines; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Neglected Diseases; Quinazolines; Structure-Activity Relationship

2015
Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis.
    Biochimica et biophysica acta, 2016, Volume: 1860, Issue:9

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Aurora Kinases; Aza Compounds; Catalytic Domain; Cell Cycle; Cell Survival; Cytokinesis; Female; Indoles; Kinetics; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Organophosphates; Protein Kinase Inhibitors; Quinazolines; Sulfonamides

2016
Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2

    Topics: Adenine; Amphotericin B; Animals; CD4 Lymphocyte Count; Class I Phosphatidylinositol 3-Kinases; Cytokines; Drug Therapy, Combination; Female; Immunomodulation; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Mice; Mice, Inbred BALB C; Parasite Load; Phosphoinositide-3 Kinase Inhibitors; Purines; Quinazolines; Quinazolinones; Spleen; T-Lymphocytes, Regulatory

2017